Post Marketing Study on Pluvicto in Korea — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Post Marketing Study on Pluvicto in Korea — Stella

Recruiting

Back to Metastatic Castration-resistant Prostate Cancer trials

Trial locations(8 sites)

South Korea

Novartis Investigative Site, Seongnam-si, Gyeonggi-do

Novartis Investigative Site, Gyeonggi-do, Korea

Novartis Investigative Site, Seoul, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~278 participants

Started

April 2025

Primary completion

May 2028

Age range

18 Years – 100 Years

Sex

Male only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov